Clin2
NCT03581773Possibly a fitRecruiting

Folic acid to reduce mouth sores during kidney cancer treatment

MucositisStomatitis

Treatments studied

Part of Digestive system, Mouth & dental clinical trials.

This Phase 2 trial tests whether folic acid can lessen mucositis (painful mouth sores) caused by certain kidney cancer medicines. You would either take folic acid or an inactive pill, and the study looks for improvement in these side effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
100 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have kidney cancer that is metastatic or locally advanced and cannot be removed with surgery
  • During your current treatment, you’ve had at least moderate mouth sores (mucositis) noted by the study grading
  • You are 18 years or older
  • A biopsy has confirmed your kidney cancer type
  • Your daily functioning is fairly good (Karnofsky score 60% or higher)
  • You are willing to follow all study visits and instructions

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07357597Recruiting· Phase 4
Preventing mouth sores during breast or lung cancer treatment

This trial tests whether a steroid mouthwash can prevent mouth sores caused by the drug Datopotamab Deruxtecan (Dato-DXd). It is for people with certain types of advanced breast cancer or lung cancer who are about to start Dato-DXd for the first time.

Tucson, Arizona
NCT07377071Not yet recruiting· Early Phase 1
Folate to reduce death risk after infection-related kidney injury

This trial tests whether giving folate (a vitamin) to people who develop acute kidney injury from an infection can lower the risk of dying in the following year.

Hong Kong, Hong Kong
NCT07736495Recruiting· Phase 2/Phase 3
Alpha-lipoic acid for chemo mouth sores in colorectal cancer

This trial tests if a supplement called alpha-lipoic acid (ALA) can protect against painful mouth sores caused by chemotherapy (FOLFOX-6) in people with colorectal cancer. If you are starting FOLFOX-6 for the first time for colorectal cancer, this study may help reduce treatment side effects.

Cairo
NCT06354712Recruiting· Phase 2
Can N-acetylcysteine prevent mouth sores during radiation?

This study tests whether a medicine called N-acetylcysteine (NAC) can prevent mouth sores caused by radiation therapy for head and neck cancer. If you are starting radiation, this trial may help protect your mouth from painful side effects.

Al Mansurah
NCT03983369Recruiting· Phase 3
Laser treatment to help prevent painful mouth sores from chemo

This trial tests whether low-level laser therapy (using special light on the mouth) can prevent or reduce mouth sores caused by chemotherapy in children and young adults. It may help you avoid painful inflammation that can affect eating, comfort, and treatment.

Villejuif, Val de Marne
NCT05892354Recruiting
Immunonutrition to reduce mouth sores after cancer treatment

This trial studies whether special nutritional supplements (immunonutrients) can reduce painful mouth sores (oral mucositis) in people with nasopharyngeal cancer after chemoradiotherapy. If you qualify, you’ll be followed with visits and lab tests to see if the supplements improve comfort and recovery.

Fuzhou, Fujian

Hear when a new Mucositis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.